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A B S T R A C T
ABPM (ambulatory blood pressure monitoring) has been considered to be a useful tool for the diagnosis and manage-
ment of arterial hypertension and is a better predictor of future cardiovascular events as compared with conventional of-
fice-based BP measurements. Despite its potential values, ABPM is not yet widely used in many clinical offices mainly
because of lack of knowledge and unavailability. Aims of this preliminary study are to determine the control of hyperten-
sion and circadian BP characteristics in patients referred to our Centre whom we enrolled in the »HRKMAT« Study-
Croatian Registry of ABPM. Although patients included in HRKMAT Study had other risk factors for cardiovascular
diseases, in this paper we analyzed differences between hypertensive diabetics (N=20) and nondiabetics (N=57). 24-
-hours ABPM was performed with an automated oscillometric device Mobil-O-Graph NG Vers.20 and office BP using
mercury sphygmomanometer. Average office BP was 139/90 mmHg, and average 24h ABPM was 130/82 mmHg. Major-
ity of hypertensive patients used antihypertensive drugs (79.2%). Diabetic patients had higher systolic BP but lower dia-
stolic BP. There were no statistically significant differences in dipping status, but earlier BP surge was noticed in reverse
diabetic dippers than in reverse non-diabetic dippers. Though no significant, there was higher prevalence of WCH (»whi-
te coat hypertension«) in diabetics, and we found MH (masked hypertension) in only two patients. These are preliminary
results on ABPM from our centre and of HRKMAT registry. Further and more valuable data and results are awaited
from the main HRKMAT database.
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Introduction
According to international guidelines, ambulatory BP
monitoring (ABPM) has been established as an impor-
tant instrument in the diagnosis and management of hy-
pertension.1,2 It gives the opportunity to evaluate 24-hour
average blood pressure (BP); daytime (awake) BP; night-
-time (asleep) BP; systolic and diastolic blood pressure
load; nocturnal dipping of the BP, BP variability, morning
BP surge, and particular conditions such as white-coat
hypertension (WCH) and masked hypertension (MH).3
Moreover, ABPM offers more accurate prognostic infor-
mation of cardiovascular outcomes than office BP read-
ings.4 Hypertension coexisting with diabetes and obesity
has a major impact on cardiovascular prognosis. Many
trials have emphasized the need for tight blood pressure
control in patients with diabetes mellitus, but ACCORD
trial proved that aggressive BP control, targeting systolic
BP of less than 120 mmHg, as compared with less than
140 mm Hg, did not reduce the rate of composite out-
comes of major cardiovascular events.5,6 Therefore, indi-
vidualized control of BP is becoming more important, es-
pecially in patients with diabetes. Abnormal patterns of
circadian blood pressure variation, evaluated by ambula-
tory blood pressure monitoring, predict cardiovascular
prognosis in diabetic patients.7 Some studies showed
that ambulatory BP control is more closely associated
with target organ damage of the brain, heart, and kidney,
even more than glycemic control, thereby ambulatory BP
control could be effective in preventing future risk of car-
diovascular disease in patients with diabetes.7
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Methods
This is a preliminary study in the framework of the
»HRKMAT« Study, an national registry of ABPM that
was organized and conducted by the Croatian Society of
Hypertension. The main aim was to determine hyperten-
sion control and overall cardiovascular and renal risks in
daily clinical practice in Croatia. The protocol of Study
has been reviewed by the appropriate ethics committee
and therefore been performed in accordance with the
ethical standards. All patients gave their informed con-
sent prior to inclusion in the study. We retrospectively
evaluated ABPM recordings from 120 patients perfor-
med with an automatic oscillometric device. Inclusion
criteria were men and women aged >18 years, mainly re-
ferred to our Centre because of previously diagnosed hy-
pertension on the basis of an office BP >140/90 mmHg.
Exclusion criteria were pregnancy, arterial fibrillation or
other cardiac arrhythmias which might make unreliable
the automatic blood pressure measurement with the
oscillometric technique and upper arm circumference
<22 cm. At the time of visit, evaluation of medical his-
tory and physical examination were performed. BP was
obtained at the office with a calibrated mercury sphyg-
momanometer after 5-minute rest in a sitting position
with a standard cuff (23 x 12 cm) or large cuff (34 x 15
cm) applied around patient’s non-dominant arm. The
first and fifth Korotkoff’s sounds were taken as the sys-
tolic and diastolic BPs. Hypertension was defined as sys-
tolic BP ³140/90 mmHg and/or taking antihypertensive
drugs. Thereafter, 24-hour ABPM was performed on
each patient’s non-dominant arm using a Mobil-O-Graph
NG Vers.20 automated noninvasive osccilometric devi-
ces. The accuracy of the device was checked against the
standard auscultatory method to ensure that the differ-
ence in BP measurements between methods did not ex-
ceed 5 mmHg. SBP, DBP and HF were recorded every 20
minutes throughout the day and every 30 minutes at
night. Daytime period was predefined from 7 a.m. until
10 p.m. and night-time period was from 10 p.m. until 7
a.m. Each ABPM monitoring dataset was automatically
scanned to remove artificial readings to preselected crite-
ria. Data was edited by omitting all readings of zero, sys-
tolic BP readings >260 mmHg, diastolic BP >150 mmHg,
all readings where the differences between the systolic
and diastolic BPs were less than 10 mmHg and heart rate
readings <20 or >200. Readings were evaluated if the
percentage of successful readings was above 80%. ABPMs
were performed on working days, and patients were in-
structed to maintain their usual activities, and return
the following morning for device removal, and to keep
their arms extended during cuff inflation. The following
ABPM parameters were evaluated: mean ambulatory
24-h systolic and diastolic BP levels, mean ambulatory
daytime systolic and diastolic BP levels, mean ambula-
tory nighttime systolic and diastolic BP levels, average
blood pressure load, daytime, nighttime and 24 hours
heart rates, BP variability. The circadian characteristics
of BP were also automatic estimated. A normal dipping
pattern was diagnosed when the reduction in average
SBP during the night period was >10% of mean SBP
during the day, if the reduction was >20% the patients
was classified as an extreme dipper, if it was less than
10% it was classified as non-dipper, and if mean night
SBP was higher than the day one, the patients was classi-
fied as a inverter. Valid registries had to fulfill pre-estab-
lished criteria, including >80% of BP successful record-
ing, 24-hour duration and >1 BP measurement per hour.
Statistical Analysis
To test differences between means Student’s t-test
and Mann-Whitney U test, as well as paired t-test and
Kruskall Wallis H test for paired data, were employed for
normally distributed and skewed data respectively. Chi-
-square test was used for categorical data. p³0.05 was
considered statistically significant. Statistical program
IBM SPSS v.19 (Chicago, IL) was used.
Results
Out of total 120 patients, 77 patients met the includ-
ing criteria. Other 43 patients were excluded mostly be-
cause of less than 80% successful readings on ABPMs,
and there was one pregnant women. There were 43
(55.8%) men and 34 (44.2%) women with the mean age
57±16 (range 22–85 years). In 93.4% (n=71) patients di-
agnoses of hypertension was established before, and 26%
(n=20) had diabetes mellitus typ 2 as well. Mean BMI
was 27.7±4.7 kg/m2 and mean waist circumference was
98.3±15.3 cm. Dyslipidemia and history of cardiovascu-
lar and cerebrovascular diseases were recognized in 36
(52.2%) and 18 (23.4%) patients, respectively. Family his-
tory of hypertension, diabetes, dyslipidemia and chronic
kidney disease were in 68.4%, 34.2%, 25.3% and in 13.2%
patients, respectively.
There were 18.2% (n=14) current smokers, 20.8%
(n=16) ex-smokers, and 61% (n=47) non-smokers. Data
on physical activity showed that only 22.1% (n=17) prac-
ticed mild physical activities (less than 200 minutes
weekly), 6.5% (n=5) moderate (200–300 minutes weekly)
and 1.3% (n=1) practiced extreme physical activity (mo-
re than 300 minutes weekly). Average office SBP/DBP
values were 139/90±30/14 mm Hg and average 24-hour
ambulatory BP values were 130/82±15/10 mm Hg (Table
1). In the whole populations, the prevalence of non-dip-
pers was 54.5%. There were 36.6% nondippers, 5.6% ex-
treme dippers and 22.5% reverse dippers for systolic BP,
and 35.2% nondippers, 11.3% extreme dippers and 16.9%
reverse dippers for diastolic BP. There were lower BP
variability in nondippers. Considering drug treatment –
79.2% (n=61) patients had been previously treated with
at least one drug. Of them 54.5% (n=42) were taking
ACE-inhibitors, 14.3% (n=11) angiotensin receptor blo-
ckers, 50.6% (n=39) calcium channel antagonists, 39%
diuretics, 37.7% (n=29) beta-blockers, 19.5% (n=15) mo-
xonidine and 5.2% (n=4) urapidil.
There were more older and overweight patients in di-
abetic group. Dyslipidemia and family history of diabetes
mellitus were also more common in diabetic group. Aver-
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age office-BP values were higher than average ABPMs in
50% diabetics and 44.2% nondiabetics. Diabetic patients
had higher systolic and slightly lower diastolic BP values
that gave result in higher pulse pressure in those pa-
tients (45.8±9.1 mm Hg vs. 54.1±11 mm Hg; t=3.266,
p=0.002). In the group of reverse dippers, diabetic pa-
tients had statistically significant earlier BP morning
surge, average around 3:36 a.m. versus nondiabetics
with average BP morning surge around 4:50 a.m. (t=
2.246, p=0.029). There were no differences in dipping
status and BP values between diabetics and nondia-
betics. In diabetic patients higher blood pressure load
(percentage of BP measurements higher than previously
defined values: 24 hours and daytime ³140/90 mm Hg
and nighttime ³120/80 mm Hg) more than 40% was
found for both systolic and diastolic BP values during the
night-time period. Significant difference in several drug
classes were observed between diabetics and non-diabet-
ics, thus both ACE inhibitors and CC antagonists were
used much more frequently in diabetic group. We failed
to find difference in usage of diuretics between the two
groups (p>0.05). Data on ABPM values and some char-
acteristics are shown in Table 1 and Table 2.
Discussion
In this preliminary study we evaluated clinical condi-
tions and BP characteristics estimated by ABPM among
hypertensive patients enrolled into the HRKMAT regis-
try in our outpatient clinic. We found that most of our pa-
tients, beside hypertension and diabetes, have also other
risk factors (dyslipidemia, overweight or even obesity,
age, family history of hypertension, diabetes or CV dis-
eases, smoking and sedentary lifestyle) which altogether
further increase cardiovascular risk. Dyslipidemia and
family history of diabetes were more prevalent in dia-
betic group. Average office BP levels were slightly higher
than average 24-hour ABPM levels that was an expected
difference.8,9 The vast majority of our patients had been
previously treated with at least one antihypertensive,
ACE and CC antagonists being the most represented
drugs (Table 2). There were no significant differences in
the average BP values between diabetics and nondiabe-
tics, but we found slightly higher systolic and slightly
lower diastolic BP among diabetic patients, that results
in higher pulse pressure (PP). Nakano et al. reported
that 24-h PP and nighttime SBP were independent pre-
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TABLE 1
BLOOD PRESSURE VALUES IN PATIENTS DIVIDED INTO THE GROUPS OF NONDIABETICS AND DIABETICS
Nondiabetics Diabetics
p
Mean SD Mean SD
Office SBP 138.31 30.52 140.90 29.26 0.743
Office DBP 90.42 13.37 89.15 15.21 0.727
ABPM (No) 45.63 6.97 47.35 6.39
Mean 24h SBP (mmHg) 129.23 15.38 133.30 14.32 0.309
Mean 24h DBP (mmHg) 83.35 10.79 79.20 8.95 0.131
Mean HR (bmp) 71.65 8.42 69.75 8.55 0.395
Mean PP (mmHg) 45.77 9.13 54.10 11.07 0.002
Daytime SBP (mmHg) 131.94 14.70 137.00 13.04 0.182
Daytime DBP (mmHg) 85.69 10.46 82.15 8.21 0.178
Daytime HR (bmp) 75.15 9.46 74.20 9.49 0.703
Daytime PP (mmHg) 46.26 9.46 54.90 11.11 0.002
Nighttime SBP (mmHg) 123.58 18.60 126.10 18.99 0.610
Nighttime DBP (mmHg) 78.69 13.13 73.50 11.71 0.126
Nighttime HR (bmp) 76.71 89.60 58.65 16.27 0.375
Nighttime PP (mmHg) 44.82 9.77 52.80 11.95 0.005
Daytime SBP load (%) 32.39 29.15 39.75 28.01 0.337
Daytime DBP load (%) 37.61 28.37 26.15 23.21 0.113
Nighttime SBP load (%) 41.94 39.39 45.10 34.40 0.754
Nighttime DBP load (%) 46.04 35.49 35.15 34.57 0.246
BP morning surge (time) 3:36 4:50 0.029
WCH (%) 44.2 50 0.660
ABPM – ambulatory blood pressure, SBP – systolic blood pressure, DBP – diastolic blood pressure, HR – heart rate, PP – pulse pres-
sure, BP – blood pressure, WCH – white coat hypertension, SD – standard deviation, No – number of measurements, p – p-value, bmp –
beats per minute
dictors of fatal and nonfatal cardiovascular events, res-
pectively11. Elevated PP is considered an indirect indica-
tor of increased arterial stiffness, particularly in older
individuals. Diabetic patients are thought to have in-
creased arterial stiffness and PP, possibly due to acceler-
ated vascular aging.11,12 We found high percentage of
nondippers (in total nondippers + reverse dippers) for
the both systolic and diastolic blood pressure in the
whole population, but we didn’t find statistically signifi-
cant differences between diabetic and nondiabetic group,
probably because of this small sample. A blunted night-
time BP decline is regarded as a prognostic marker of
cardiovascular event, both in hypertensive subjects and
in the general population.13 Eguchi et al. evaluated the
data on the effect of risen pattern of BP on future CV
events and showed that it was associated with a 150% in-
crease in the risk of CV disease both in diabetes and es-
sential hypertension.14 In type 2 diabetes studies and
meta-analysis indicate that 24 hour PP and reduced
nighttime BP fall or reverse dipping predict organ dam-
age progression, total cardiovascular events and all-cau-
se mortality.15 Abnormal patterns of circadian blood
pressure variation, evaluated by ambulatory blood pres-
sure monitoring, predict cardiovascular prognosis in dia-
betes mellitus.7 There were high percentage of over-
weight and obese patients. Statistically significant hig-
her percentage of patients with central type obesity was
found in diabetics group. Some studies reported higher
ABPM in patients with metabolic syndrome (MetS), but
they had mostly included older individuals and those
with higher office BP than those without MetS. Pooled
data suggested a higher risk of nondipping status in pa-
tients with MetS.15 In a study on evaluation ABPM in
nondiabetic untreated hypertensives Hermida et al.
found that the prevalence of nondipping status was sig-
nificantly higher in patients with MetS and the single
most relevant factor in definition of MetS associated
with nondipping was elevated waist circumference.16
We found blood pressure loads higher than 40% for
both systolic and diastolic BP in nondiabetics, and for
systolic in diabetics. Blood pressure load elevation is as-
sociated with the development of target-organ damage
and higher cardiovascular risk, especially when daytime
BP is higher than normal in 40% readings, even in mild
hypertension, and therefore it should be treated ear-
lier.17–20
Studies in hypertensive individuals, in diabetic pa-
tient, and also in general populations showed that the
nighttime SBP more accurately predicted future cardio-
vascular events than the daytime SBP, especially in hy-
pertensive treated patients.21 Impaired circadian modu-
lation of sympathovagal activity is probably involved in
the reduced nocturnal BP fall observed in diabetic pa-
tients.12,22
In the group of reverse dippers, circadian acrophase of
BP (i.e. the time of the maximum of the BP) in diabetic
patients occurring 1.5 hour earlier than in non-diabetics.
Matteucci et al. showed that people with diabetes melli-
tus, both type 1 and 2, have their circadian acrophase
(i.e. time of the maximum of the DBP) of diastolic blood
pressure occurring 2–4 hours earlier than normotensive
and hypertensive subjects.23 Cardiovascular events tend
to have higher incidences in the early morning hours,
and morning BP or the early morning BP surge may con-
tribute to this phenomenon.24
Some studies shown that the 24-hour BP variability is
also an independent predictor of target organ demage.8,25
We found lower BP variability in the group of reverse
dippers, probably because of their continuous 24-hour
high blood pressures.
Regarding WCH, we found higher but non significant
prevalence in diabetic group. White coat effect has been
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TABLE 2
CHARACTERISTICS OF ENROLLED DIABETIC AND NONDIABETICS
Nondiabetics Diabetics p
Age 53.3 63.5 0.003
Gender 32/57 11/20 NS
BMI (kg/m2) 27.44±4.92 28.61±4.37 NS
Mean waist circumference (cm) 95.9±15.5 105±13 0.021
Hypertension (%) 92.9 95 NS
Dyslipidemia (%) 37.4 95 <0.001
Family history of HA (%) 71.4 60 NS
Family history of DM (%) 25.0 60 0.005
Smoking status (%) 36.8 45 NS
ACE inhibitor (%) 47.4 75 0.033
CC antagonists (%) 42.1 75 0.011
Diuretics (%) 35.1 50.0 NS
ACE – angiotensin-converting enzyme, CC – calcium channel, BMI – body mass index, DM – diabetes mellitus, HA – arterial hyperten-
sion, p – p-value, NS – no significance, Mean±standard deviation
considered a low-risk factor for CV events; however,
when coexistent with diabetes WCH increases risk.26
Kramer et al. investigated the effect of WCH on the im-
pact of microvessel disease and showed that the WCH in
diabetes typ 2 was associated with two-fold higher risk of
diabetic retinopathy and nephropathy.27 Masked hyper-
tension is more frequent in diabetes and seems to be
associated with higher risk of target organ damage
(LVIM).15 Higher prevalence of masked hypertension in
diabetics could be a sign of inadequate and difficult to
treat hypertension in these pts. We couldn’t analyze
differenence on MH in our patients because of too small
sample.
In summary, BP determination by ABPM is capable of
more adequately stratifying hypertensive patients, espe-
cially those with diabetes mellitus and other cardiovascu-
lar risk factors. Therefore, we believe that ABPM should
be more used in our patients for better risk stratification
and improving CV outcomes. Main limitations of this
preliminary study are small sample size and its cross-sec-
tional design, which precludes causal and temporal infer-
ences. More findings on ABPM in our patients are ex-
pected after finishing HRKMAT Study and a continuous
follow up.
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KONTINUIRANO AMBULATORNO MJERENJE ARTERIJSKOG TLAKA KOD HIPERTONI^ARA
SA [E]ERNOM BOLESTI-PRELIMINARNI REZULTATI
S A @ E T A K
KMAT (kontinuirano ambulantno mjerenje arterijskog tlaka) je korisna metoda u dijagnostici i upravljanju arterij-
ske hipertenzije i bolji predskazatelj budu}ih kardiovaskularnih doga|aja u usporedbi sa konvencionalnim ambulant-
nim mjerenjem AT (arterijskog tlaka). Unato~ potencijalnoj korisnosti KMAT jo{ uvijek nije dovoljno zastupljen u svako-
dnevnoj klini~koj praksi, uglavnom zbog pomanjkanja znanja te nedostupnosti aparata. Cilj ovog preliminarnog istra`i-
vanja jest odrediti kontrolu hipertenzije kao i karakteristi~ni dnevni ritam AT kod pacijenata iz na{eg centra koji su
uklju~eni u »HRKMAT« Studiju – Hrvatski registar kontinuiranih mjera~a tlaka. Iako pacijenti uklju~eni u ovu studiju
imaju vi{estruke faktore rizika za kardiovaskularne bolesti, u ovom ~lanku smo analizirali razlike izme|u hiperten-
zivnih dijabeti~ara (N=20) i nedijabeti~ara (N=57). KMAT je u~injeno sa automatiziranim oscilometrijskim ure|ajem
Mobil-O-Graph NG Vers.20. Prosje~ni ambulantni krvni tlak je bio 139/90 mmHg, a srednji 24-satni krvni tlak 130/82
mmHg. Ve}ina hipertenzivnih bolesnika je uzimala antihipertenzivne lijekove (79,2%). Dijabeti~ari su imali vi{i sisto-
li~ki, ali ni`i dijastoli~ki tlak. Nije bilo statisti~ki zna~ajne razlike u »dipping« statusu, ali zamije}en je raniji jutarnji
porast AT kod dijabeti~ara sa no}nim porastom tlaka u odnosu na nedijabeti~are s no}nim porastom tlaka. Iako nismo
na{li statisti~ki zna~ajanu razliku »hipertenzija bijelog ogrta~a« je bila ~e{}a kod dijabeti~ara, a samo dvoje pacijenta je
imalo maskirnu hipertenziju. Ovo su preliminarni rezultati KMAT-a iz na{eg centra i HRKMAT registra. Vi{e vrijed-
nijih podataka i rezultata se o~eukuje iz glavne HRKMAT baze podataka.
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